Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-27

Clinical Trial Update: Effect of Dairy Product Matrices on Insulin Resistance in People with Overweight and Obesity and Prediabetes [NA]

View source ↗

Summary

The clinical trial evaluating the effect of dairy product matrices on insulin resistance in people with overweight/obesity and prediabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: PreDiabetes, Overweight and Obesity | NA | Status: WITHDRAWN